Antibiotic Bone Cement Likely To Be Used In Treating Bone Infection In Future

Antibiotic Bone Cement Likely To Be Used In Treating Bone Infection In Future

Experts are debating on use of antibiotic bone cement instead of the normal bone cement in dealing with bone infection that arises after total knee or hip replacement surgery. These discussions are being witnesses at a period when cases of infection of the bone and replacement surgery (knee and hip) are on the rise.

In a meeting recently held at Plymouth, experts working with ECRI, and non-profit institute that focus on educating medics and other health experts were holding talks on the possibility and viability of using antibiotic cement instead of the standard cement when carrying out bone replacement. This is in line with coming up with a more feasible, long-lasting, and safe solutions for people who have recently gone through the procedure.

Bone infectionRecords show that one of the leading causes of bone infections is inflammation after going through a surgical procedure such as hip or knee replacement. In order to strengthen and protect the bone structure, bone cement is used on the target region; however, experts are considering moving from the normal cement in favor of antibiotic type which is said to be more durable and effective against bone infections.

Discussions surrounding use of antibiotic cement have been ongoing for a long time and the medical fraternity as well as general public hope to see a concrete solution on the way forward. ECRI Institute aims at addressing the benefits of the normal and antibiotic cement, health technology assessments, get opinions from experts, and also viability of the methods in tackling bone infections. With proper guidance, the healthcare givers will know which method to adopt and the patients will be more assured of a better mode of treatment.

According to Diane Robertson, the director of health technology assessment at ECRI Institute, analysis and inputs from bone experts who include orthopedics, surgeons, spine product overseers, clinical trauma experts, supply chain professionals and others will help the institute come up with a clearer picture on whether antibiotic cement is better than the standard cement currently in use.

Issues that play a role in the cement finding its way in the market include clinical proof that shows the cement helps prevent bone infection, availability of the cement in different regions, cost benefit analysis, market share as well as pricing.

Timothy Browne, ECRI Institute’s director of Price Guide advisory service believes that looking at the market share currently held by antibiotic cement and looking and the minimum, average, as well as maximum price is critical in coming up with the way forward. The goal is to ensure the public gets a product that is more effective, affordable, and within reach.